This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
FDA Physicians Side effects 
World of DTC Marketing
JUNE 23, 2021
One agency FDA adviser, resigning from his committee post in protest, called it “probably the worst drug approval decision in recent U.S. Therefore, I find it hard to understand how so many physicians could show “strong interest” in prescribing a drug with so many questions vs. answers. government.
218 
World of DTC Marketing
JULY 21, 2021
The FDA needs to study what people do when they see a DTC ad. They research the drug online and ask their physician about it if they decide it’s a treatment option. ” Patients want to understand how the drug works and the potential side effects before starting therapy. DTC ads do NOT lead to unnecessary Rxs.
285 
World of DTC Marketing
FEBRUARY 2, 2022
Never mind that physicians have turned against the drug Biogen wants to fight the decision because of their business needs. While some doctors have been eager to start prescribing the newly approved drug, others had criticized the FDA for clearing the drug before studies proved it works. Top researchers who advised the U.S.
World of DTC Marketing
JANUARY 1, 2022
1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Here are things I believe are more realistic.
244 
World of DTC Marketing
DECEMBER 29, 2021
The demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. There are also several physicians chiming in with their concerns over the long-term use of the drug. I reached out to some physicians to ask their opinion, and it varied. Unfortunately, the hype is going to exceed reality.
191 
World of DTC Marketing
AUGUST 10, 2022
While there is a segment that sees the drug as a “quick fix” to lose weight, others are skeptical and want to know more about side effects and costs. They’re using label and FDA-friendly language, which isn’t what patients want to hear. So what’s the opportunity for DTC marketers?
252 
World of DTC Marketing
NOVEMBER 5, 2021
“Obesity is multifactorial, meaning many factors are involved and go from genetics, lifestyle, mental health issues (such as trauma) to medication side effects,” says Dr. Viana, Clinical Director Yale Medicine Metabolic Health & Weight Loss Program. Many factors contribute to obesity. Click to Tweet.
271 
World of DTC Marketing
DECEMBER 23, 2020
How do physicians feel about patients asking for a new drug via a telehealth visit, and can the prescriber evaluate whether a patient is a good candidate or a new drug? What are the side effects? The FDA can be myopic when researching how consumers view and react to DTC. Is TV the best channel?
249 
World of DTC Marketing
OCTOBER 19, 2020
We are already seeing a drop in the number of people who are willing to get a COVID-19 vaccination and until trust can be re-established with the FDA and the CDC I expect that number to remain high. Forward-thinking pharma marketers are thinking about ways to integrate DTC marketing into telehealth and at physician portals.
180 
Legacy MEDSearch
OCTOBER 25, 2022
Food and Drug Administration (FDA) granted Breakthrough Device Designation for the Company’s EndoStim System. “We are pleased that the FDA has recognized the therapeutic potential of the EndoStim System as a new treatment in development for drug refractory GERD,” said Eric Goorno, Chief Executive Officer of EndoStim. .
World of DTC Marketing
JULY 5, 2022
Lilly’s new diabetes drug is being talked about all over social media because of its weight loss properties, but what’s not mentioned is that it requires a diet modification and has side effects that can cause more severe health issues. Why don’t doctors have the “the talk”?
200 
Pharmaceutical Technology
AUGUST 12, 2022
In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses.
Pharmaceutical Technology
JULY 20, 2022
On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .
Pharmaceutical Technology
DECEMBER 7, 2022
On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.
64 
Pharmaceutical Technology
APRIL 11, 2023
Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies. During the two-year project, the companies will assess the mental health side effects of the asthma drug, montelukast.
59 
pharmaphorum
JANUARY 20, 2023
Eli Lilly has been unable to secure an accelerated FDA approval for its anti-amyloid Alzheimer’s disease therapy donanemab based on mid-stage clinical results, but says it remains on track to file a traditional submission around the middle of this year. Final results from CLARITY-AD are also due in the first half of this year.
64 
Pharma Leaders
MAY 18, 2023
The US Food and Drug Administration (FDA) has accepted Ardelyx’s resubmitted New Drug Application (NDA) for XPHOZAH (tenapanor) to control serum phosphate in adult patients with chronic kidney disease on dialysis who have had an insufficient response or intolerance to a phosphate binder therapy.
Pharmaceutical Technology
MAY 5, 2023
The sale of an illegally imported supplement being marketed as a weight-gain enhancer has been associated with cases of dizziness, cognitive impairment, and sedation, according to the US Food and Drug Administration (FDA). In this case, the woman had taken apetamin in the form of cyproheptadine, lysine, and vitamin syrup.
pharmaphorum
DECEMBER 4, 2022
“Obviously, we want to be extremely careful and certain that it will work well before putting a device in a human, but we’ve submitted, I think, most of our paperwork to the FDA,” he said, according to video from the event posted in Musk’s Twitter platform. — Physicians Committee (@PCRM) November 30, 2022. Take action!
93 
European Pharmaceutical Review
MAY 23, 2024
Last month, CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) was the first BCMA-targeted CAR-T cell therapy to be approved for second-line treatment of multiple myeloma by the US Food and Drug Administration (FDA). CAR T-cell Therapy and its side effects [Internet]. 2 Why does CARVYKTI have potential in multiple myeloma?
pharmaphorum
SEPTEMBER 16, 2022
Minor side effects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of side effects. However, side effects do happen. Regarding both common cold and headache, they are as well among the side effects reported for similar drugs.
72 
pharmaphorum
JULY 18, 2022
The Dutch biotech submitted the ADC to the FDA last week and said this morning the EMA had formally started its review of the drug for HER2-positive, locally advanced or metastatic breast cancer that can’t be treated with surgery. “There is a dire need to provide an alternative treatment option to these patients.”
59 
Legacy MEDSearch
JUNE 15, 2023
Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.
98 
pharmaphorum
AUGUST 11, 2022
Next, pharmacists review the participant’s genetic results – along with health data such as drug, lifestyle, and food interactions – to customize a “Medication Action Plan” that members’ physicians can access to determine which drugs should be prescribed to increase safety and efficacy.
80 
PM360
AUGUST 9, 2022
Levrx also engages physician groups and members directly, giving healthcare consumers the information needed at the point of care to keep costs low, avoid prescription rewrites, and prevent cost-related non-adherence. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension. CareTrack Health.
105 
Medgadget
FEBRUARY 17, 2023
Currently, the awkwardness of conventional laparoscopic tools keeps many physicians from using them in a variety of cases. Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. are still done in an open fashion.
80 
Legacy MEDSearch
JUNE 28, 2023
3,6 It stops hemangioma growth, reduces the lesion, and accelerates hemangioma regression, especially in the superficial IH, without serious side effects. Port wine stains affect 1 in every 300 infants, and over time usually get darker and thicker, making early onset treatment critical for optimal results. Geronemus, M.D.,
52 
PM360
OCTOBER 13, 2023
Of the eight FDA-approved weight loss drugs on the market, these two are making waves for doctors who believe they represent “a new era for weight loss medications,” and “changing options and giving hope.” They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP).
59 
Legacy MEDSearch
JULY 19, 2023
“Currently, prostate cancer patients find themselves in the difficult position of balancing the oncological risks of the disease with the life-altering side effects that can often accompany traditional treatments. ” As the second most common cancer in U.S. market clearance.
52 
pharmaphorum
OCTOBER 13, 2022
In October 2022, the companies announced their plan to file exagamglogene autotemcel, the CRISPR/Cas9- edited therapy, for a rolling review with the FDA. Earlier this year, the US Food and Drug Administration (FDA) approved the first potentially curative gene therapy to treat beta-thalassemia. Novartis also recently inked an up-to $1.5
European Pharmaceutical Review
DECEMBER 27, 2023
5 Subsequently, transplant centres administering CAR T cells in various pharma-sponsored clinical trials had to establish multi-disciplinary teams, including not just haematologists and oncologists but also intensive-care physicians and nurses, nephrologists, neurologists, pharmacists and others. FDA; 2022 [cited 2023 Mar].
104 
Silver Line CRM
NOVEMBER 20, 2020
Whether it’s a desperately needed vaccine for a contagious disease, new research on side effects or success of treatments, or a life-saving treatment using new technology, pharmaceutical marketers must be ready for whatever new developments arise. Market research only tells part of the story.
52 
Silver Line CRM
MARCH 22, 2021
What side effects are they talking about? . You don’t need 25 pieces of information from them to set up a phone call or follow-up with the physician to learn more. So, how can you be empathetic and put the patient at the forefront of every decision you make? Listen to them. Organizations need to: Collect social listening data.
52 
Quantified
APRIL 18, 2022
With only 50 novel drug approvals by the FDA across the entire industry in a typical year, the opportunity to build the institutional knowledge and refine launch marketing and sales fundamentals is an order of magnitude lower than, say, in consumer goods where there might be upwards of 4 brand initiatives a year.
52 
Pharmaceutical Representative Training
JUNE 22, 2024
They must be familiar with the different national authorities; the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regulations that govern the pharmaceutical marketing and sales. Communication Skills: Effective communication is essential when interacting with HCPs in order to build relationships in sales.
52 
Rep-Lite
MARCH 14, 2024
Networking Skills: Actively networking within the healthcare industry enables sales reps to establish and nurture relationships with key stakeholders, including physicians, nurses, administrators, and purchasing managers. Sales reps must demonstrate honesty, integrity, and reliability in all interactions.
Pharmaceutical Technology
AUGUST 12, 2022
In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The other therapy Mitsubishi Tanabe Pharma’s Radicava is only effective in the early stages of ALS.
98 
pharmaphorum
JULY 6, 2022
Some patients with COVID-19 will be able to get easier access to Pfizer’s oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug. I've worked, including through Test to Treat, to expand access to Paxlovid, a pill shown to curb the worst effects of COVID-19. It made $1.5
96 
Pharma Marketing Network
JUNE 11, 2020
I was at Physicians Online at the time. Yeah, I even wanted to wear the shirt to this FDA meeting. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. You were PharmInfoNet.
52 
Legacy MEDSearch
OCTOBER 25, 2023
This large sample size study gives physicians and patients alike the evidence-based confidence that the impact of Remote Electrical Neuromodulation (REN) with Nerivio is sustainable over a long time. We designed Nerivio with exactly these requirements in mind.”
52 
pharmaphorum
DECEMBER 15, 2022
Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Despite the slap on the wrist, the campaign was highly effective and there is no sign of this approach going away.
77 
PM360
AUGUST 26, 2024
Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. Powerful patient opinion leader groups and advocacy organizations and their physician expert champions are a key starting point. Bright Spots.
52 
Impetus Digital
JANUARY 3, 2023
Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Despite the slap on the wrist, the campaign was highly effective and there is no sign of this approach going away.
52 
World of DTC Marketing
NOVEMBER 16, 2020
The problem is that until the data is viewed by scientists and physicians outside the industry their claim should be viewed with a high dose of skepticism. The announcement of the effectiveness is one thing, but approval is another. ” COVID-19 Fatigue. The resurgence of COVID-19 is partly due to COVID-19 fatigue.
203
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content